- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04674046
Deep Deltoid Ligament Integrity in Weber B Ankle Fractures - Mini-invasive Arthroscopic Evaluation.
Deep Deltoid Ligament Integrity in Ankles With Isolated Weber Type B Fractures - Mini-invasive Arthroscopic Evaluation Using the Arthrex NanoScope.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Purpose and research question The main purpose is to evaluate integrity in the deep deltoid ligament in ankles with isolated Weber type B fractures using a minimally invasive Nanoscopic technique. Further results of a Nanoscopic evaluation will be correlated to the results of gravity stress and weightbearing radiographs. Additionally, the Nanoscopic evaluation will be used to assess associated injuries including cartilage and syndesmotic lesions.
Methods Primary evaluation will be done in the acute setting. All isolated Weber type B fractures without radiological signs of instability (medial clear space of 7 mm or less) on initial non-weightbearing radiographs presenting to our clinic will be evaluated for inclusion. Nanoscopic evaluation will determine stability for all patients with radiographic measurements indicating "uncertain stability". "Uncertain stability" of the ankle is assumed when at least one out of 3 (plain-, gravity- or weightbearing-) radiographs is showing instability. Like Seidel et al. (2017), in the event of a MCS of over 7 mm on initial non-weightbearing radiographs the ankle is considered unstable and will be evaluated for surgery. These patients will not be evaluated for inclusion.
For radiographic tests the size of the MCS will make up an indirect measurement of deltoid ligament capacity. The MCS is defined as the distance between the medial border of the talus and the lateral border of the medial malleolus on a line parallel to and 5 mm below the talar dome on anteroposterior radiographs. A MCS of 5 mm or less defines the ankle as stable. An MCS >5 mm AND 1 mm or more increase compared to the contralateral (non-injured ankle) ankle defines the ankle as unstable.
Plain-, weightbearing- and gravity stress radiographs and nanoscopic evaluation will be done 3-14 days after injury at the outpatient clinic. The radiographic test battery will be done prior to nanoscopy. Only patients demonstrating at least one positive stress radiograph (weightbearing or gravity) or a plain radiograph with a MCS measurement above the threshold (5 mm AND 1 mm or more increase compared to the contralateral ankle) will undergo nanoscopic evaluation.
Participants with "uncertain" stability will be assigned to non-operative or surgical treatment based on ankle stability evaluation using results from the NanoScopic evaluation consistently. Stability is assumed when the posterior part of the deep deltoid ligament is visible and intact. Stable ankles will be treated non-operatively with a functional brace (AirCast) for 6 weeks. Participants will be instructed to bear weight as tolerated and to actively do standardized range-of-motion exercises. Unstable ankles will be operated on. Standard operative treatment is open reduction and internal fixation of the fracture using plate and screws. The goal is an osteosynthesis that allow for early range-of-motion exercises, but weightbearing is usually not tolerated until 6 weeks postoperatively.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Marius Molund, MD, PhD
- Phone Number: +4790093988
- Email: mariusmolund@hotmail.com
Study Contact Backup
- Name: Martin G Gregersen, PT, Msc
- Phone Number: +4748171718
- Email: martinggregersen@gmail.com
Study Locations
-
-
Østfold
-
Sarpsborg, Østfold, Norway, 1719
- Recruiting
- Østfold HT
-
Contact:
- Marius Molund, MD, PhD
- Phone Number: +4790093988
- Email: mariusmolund@hotmail.com
-
Contact:
- Martin G Gregersen, PT, Msc
- Phone Number: +4748171718
- Email: martinggregersen@gmail.com
-
Principal Investigator:
- Marius Molund, MD, PhD
-
Sub-Investigator:
- Martin G Gregersen, PT, Msc
-
Sub-Investigator:
- Fredrik A Nilsen, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Patients:
- With isolated Weber type B fractures without radiological signs of medial clear space widening on initial plain radiographs (MCS < 7mm).
- Demonstrating at least one positive stress radiograph (weightbearing or gravity) or a plain radiograph with a MCS measurement above the threshold (5 mm AND 1 mm or more increase compared to the contralateral ankle) (WP2).
- 18-80 years of age.
- With pre-injury walking ability without aids.
Exclusion Criteria:
Patients:
- With fracture of the medial malleolus, pre-hospital closed fracture reduction, open fracture, fracture resulting from high-energy trauma or multi-trauma and pathologic fracture.
- With poorly regulated Diabetes Mellitus type 1 and 2, neuropathies and generalized joint disease such as Rheumatoid Arthritis.
- That are assumed not compliant (drug use, cognitive- and/or psychiatric disorders).
- With previous history of ipsilateral ankle fracture.
- With previous history of ipsilateral major ankle-/foot surgery.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Nonoperative treatment if deltoid ligament is intact
AirCast Air-stirrup (DJO Global) functional orthosis for 6 weeks.
|
Patients where the ankle is evaluated as stable using arthroscopy will be treated with conservative treatment using a functional brace (AirCast) for 6 weeks.
Participants will be instructed to bear weight as tolerated and to actively do standardized range-of-motion exercises.
Other Names:
All participants, regardless of group allocation, will receive education focusing on basic self- management.
A physiotherapist will be responsible for the education.
The intention will be to increase self-efficacy and encourage self-management.
Participants will learn about crutch walking, cast or orthosis usage, loading principles, be advised to stay physically active within proper restrictions and how to rest and reduce pain and swelling of the ankle in the acute phase.
Participants will also receive a standard information brochure about the condition, treatment and basic self-management.
|
|
Experimental: Operative treatment if deltoid ligament is ruptured
Open reduction, internal fixation of the fibular fracture using plate and screws.
|
All participants, regardless of group allocation, will receive education focusing on basic self- management.
A physiotherapist will be responsible for the education.
The intention will be to increase self-efficacy and encourage self-management.
Participants will learn about crutch walking, cast or orthosis usage, loading principles, be advised to stay physically active within proper restrictions and how to rest and reduce pain and swelling of the ankle in the acute phase.
Participants will also receive a standard information brochure about the condition, treatment and basic self-management.
Patients where the ankle is evaluated as unstable using arthroscopy will be operated on.
Standard operative treatment is open reduction and internal fixation (ORIF) of the fracture using plate and screws.
The goal is an osteosynthesis that allow for early range-of-motion exercises, but weightbearing is usually not tolerated until 6 weeks postoperatively.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Manchester-Oxford Foot Questionnaire (MOXFQ)
Time Frame: 6 weeks, 12 weeks, 52 weeks, 104 weeks
|
The MOXFQ (Dawson et al., 2006) was developed to measure perceived foot- specific functioning and health-related quality of life.
The MOXFQ is supported as the current most valid, reliable and responsive ankle-specific instrument (Jia, Huang, & Gagnier, 2017) and has been validated for use in ankle pathology (Dawson et al., 2011).
It is available in Norwegian, but it has not been validated in its translated form.
The score comprises a total of 16 items.
They are distributed within 3 dimensions; foot pain (5 items), walking/standing (7 items) and social interaction (4 items) where all items are scored on a 5-point Likert scale, scored 0 (best) to 4 (worst).
The MOXFQ index (Morley et al., 2013) will be used, where scores are converted to a metric (0-100) scale.
Lower scores indicate less pain and higher levels of ankle/foot functioning (Morley et al., 2013).
|
6 weeks, 12 weeks, 52 weeks, 104 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Registration of adverse events
Time Frame: 104 weeks.
|
Adverse events including malalignment, deep vein trobosis, nerve injury, wound infection, delayed wound healing and crossover to surgery (including reason for crossover).
|
104 weeks.
|
|
Registration of fracture union
Time Frame: 12 weeks.
|
Fracture union will be registered as union/nonunion and defined as concurrent radiographic evidence of fracture union and pain-free palpation over the fracture location.
|
12 weeks.
|
|
Registration of the incidence of concomitant cartilage injuries.
Time Frame: Baseline.
|
Evaluated peroperatively by minimally invasive arthroscopy.
|
Baseline.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Marius Molund, Md, PhD, Ostfold HT
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 123245
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ankle Fractures
-
The University of Texas Health Science Center,...AO Trauma North AmericaCompletedDisplaced Ankle FracturesUnited States
-
Hadassah Medical OrganizationCompleted
-
Shaikh Zayed Hospital, LahoreCompletedBimalleolar Ankle FracturePakistan
-
Sohag UniversityRecruitingFragility Ankle Fractures and Complex Distal Tibial FracturesEgypt
-
University of ArizonaActive, not recruitingUnstable Ankle Fractures With Syndesmotic DisruptionUnited States
-
Nova Scotia Health AuthorityBauerfeindNot yet recruitingAnkle Fracture | Ankle ArthrodesisCanada
-
Encore Medical, L.P.RecruitingBimalleolar Ankle FracturesUnited States
-
Brian W. NoehrenRecruiting
-
Cairo UniversityCompleted
-
University Hospital, GrenobleRecruitingAnkle Fractures:Osteosynthesis of High-Risk Ankle Fractures Using Locked Fibula NailsFrance
Clinical Trials on Nonoperative treatment
-
Dr. E.M.M. (Esther) Van Lieshout PhD MScEnrolling by invitation
-
Boston Children's HospitalTexas Scottish Rite Hospital for ChildrenActive, not recruitingPsychological Stress | Osteochondritis Dissecans KneeUnited States
-
Central Finland Hospital DistrictUniversity of JyvaskylaActive, not recruiting
-
Finnish Defense ForcesCompleted
-
Wake Forest University Health SciencesRecruitingPelvic Fracture | Acetabular Fracture | Pubic Rami FractureUnited States
-
Mayo ClinicTerminatedShoulder Fractures | Arthropathy | Humerus Fracture | Shoulder Injury | Shoulder Arthropathy Associated With Other Conditions | Arthropathy Shoulder | HumerusUnited States
-
Yale UniversityTerminatedSmall Bowel ObstructionUnited States
-
Peking University Cancer Hospital & InstituteRecruiting
-
Tampere University HospitalTurku University Hospital; Helsinki University Central Hospital; Oulu University... and other collaboratorsRecruitingRectal Cancer | Rectal AdenocarcinomaFinland, Estonia
-
University of Southern CaliforniaUniversity of Maryland, Baltimore; McMaster University; Orthopaedic Trauma AssociationRecruitingInternal Fixation | Fragility Fracture | Multiple Closed Pelvic Fractures With Disruption of Pelvic Ring | Nonoperative CareUnited States, Spain